Dear Reader,
Shortwave Life Sciences Plc (AQSE: PSY) PSYCH Symposium London 2025
PSYCH Symposium London 2025: Shortwave Life Sciences to Present Emerging Clinical Research as Gold Partner
Shortwave Life Sciences (AQSE: PSY) publishes patent application for buccal film formation
Shortwave Life Sciences PLC (PSY), listed on the Aquis Stock Exchange Growth Market, the UK’s leading healthcare company focused on developing innovative treatments for anorexia nervosa, is pleased to announce
Shortwave Life Sciences PLC (AQSE: PSY) Appointment digital asset treasury partner Archax
Company appoints digital asset treasury management partner Archax
Shortwave Life Sciences (AQSE: PSY) £250K Raised, Biotech Meets Digital Assets
StockBox spoke to Shortwave Life Sciences co-founder Stephen Murphy and executive chairman Rolf Gerritsen following the company’s £250,000 fundraise. They discussed the company’s strategic expansion into digital asset management, upcoming
Shortwave Life Sciences PLC (AQSE: PSY) £250k Fundraising, New Directors & Review
£250,000 Placing at £0.0025 per share Appointment of Company Directors and Adviser Comprehensive Business Review to Drive Company Repositioning